We have a special assignment: your health
Vaccines improve the quality of life by preventing serious illnesses. They play a key role in promoting public health. We conduct reliable research on the quality, safety and efficacy of vaccines.
WHY FVR?
- Capability to enroll high volumes of participants for clinical trials (thousands) and large pragmatic trials (tens of thousands)
- Decades of vaccine study experience from >160 studies throughout all age groups
- Strong references for post-licensure studies, favourable Finnish operating-environment
- Core focus on vaccine trials
- Continuous development mindset, agility and drive to innovate together with partners
Key figures (year end 2023)
Our research expertise
We study vaccines with decades of experience and internationally recognized, high-quality scientific expertise. Our comprehensive network of clinics offers first-class prerequisites for this. We offer clinical expertise in phases 1-4 of vaccine research as well as investigations into the effectiveness and safety of vaccines already in use. We have strong expertise in Real-World Evidence (RWE) studies and pragmatic vaccine trials, utilizing Finland’s comprehensive health registers and data resources.
We promote science-based vaccination expertise and public acceptance in Finland and in the world by means of high-quality vaccine research.
Newsfeed
-
Changes in the leadership team of FVR
Three new members have been appointed to the FVR – Finnish Vaccine Research leadership team. Katja Volanto-Lumppio, Head of Research Services and Satu Grönberg, Head of People, joined the leadership team on 1 December 2024. Laura Grant has been appointed as Director, Marketing and Communications starting on 10 January 2025. Laura will be responsible for…
Research clinics
-
FVR, Espoo Clinic
-
FVR, Helsinki South Clinic
-
FVR, Järvenpää Clinic
-
FVR, Kokkola Clinic
-
FVR, Oulu Clinic
-
FVR, Pori Clinic
-
FVR, Seinäjoki Clinic
-
FVR, Tampere Clinic
-
FVR, Turku Clinic
-
RWE-studies